BiotechTubeBiotechTube
Home/Rani Therapeutics/Mir Imran
MI

Mir Imran

Chairman and Chief Executive Officer

Rani Therapeutics

Therapeutic Areas

OsteoporosisInflammatory DiseasesAutoimmune DiseasesEndocrinology

Rani Therapeutics Pipeline

DrugIndicationPhase
RT-102OsteoporosisPhase 1
RT-111Inflammatory Diseases (Ustekinumab Biosimilar)Phase 1

Leadership Team at Rani Therapeutics

TI
Talat Imran
President and Chief Operating Officer
TB
Tiffany Barry
Chief Financial Officer
View full Rani Therapeutics profile